Not exact matches
Researchers report that bococizumab had short - term benefits on lowering cholesterol levels and significantly reduced the risk of cardiovascular events by 21 percent compared to
placebo among those who had baseline LDL cholesterol levels of greater
than 100 mg / dL.
During the study period, the incidence of serious adverse events was no higher
among those receiving inosine
than among the
placebo group.
Among patients with acute, low back pain presenting to an emergency department, neither the nonsteroidal anti-inflammatory drug (NSAID) naproxen combined with oxycodone / acetaminophen or the muscle relaxant cyclobenzaprine provided better pain relief or improvement in functional outcomes
than naproxen combined with
placebo, according to a study in the October 20 issue of JAMA.
In those studies, the percentage of people on an atypical antipsychotic who gained a clinically significant amount of weight was between 2 and 10 times greater
than the comparable rate
among people taking
placebo.
A previous trial evaluating fluoxetine found no effect on alcohol consumption, but fluoxetine did reduce Ham - D - 24 scores more
than placebo treatment
among the 14 % of study subjects who had comorbid depression.1